ZYME – zymeworks inc. (US:NASDAQ)
Stock Stats
News
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting [Yahoo! Finance]
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting [Yahoo! Finance]
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
Zymeworks (ZYME) had its price target raised by HC Wainwright from $32.00 to $46.00. They now have a "buy" rating on the stock.
Form 144 Zymeworks Inc. Filed by: Smith Jeffrey T L
Form S-8 Zymeworks Inc.
Form 8-K Zymeworks Inc. For: Mar 02
Form 10-K Zymeworks Inc. For: Dec 31
Form 8-K Zymeworks Inc. For: Mar 02
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.